Recently, GenScript made an announcement that demonstrated its commitment to supporting full non-viral cell therapy development into IND-enabling and clinical stages GenScript USA Inc., one of the ...

Market Development ManagerDeNovix Inc. In this interview, Andrew Jones discusses the importance of quality control in next-generation sequencing and the effect that a poorly followed protocol can have ...

Assessment for anti-dsDNA antibodies provides some of the most significant challenges in autoantibody serology testing. Anti-dsDNA antibodies are an important biomarker for systemic lupus ...

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.

Systemic lupus erythematosus (SLE) is characterized by autoantibody production, with anti-dsDNA antibodies (anti-dsDNA) being a key indicator for SLE diagnosis and disease monitoring. A new study ...

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient’s cells. However, most genetic disorders are caused by dozens or even thousands of ...

The data could help clinicians better identify patients who are good fits for belimumab after rituximab. A new study has identified biomarkers that may help predict which patients with systemic lupus ...

The upper right portion illustrates viral nucleosome-like particles formed by co-occurring viral histone triplets and singlets. On the lower right, a network depicts distinct types of viral ...